Abstract: Amidine-type peptide bond isosteres were designed based on the substitution of the peptide bond carbonyl (C=O) group with an imino (C=NH) group. The positively charged property of the isosteric part resembles the reduced amide-type peptidomimetic. The peptidyl amidine units were synthesized by the reduction of a key amidoxime (N-hydroxyamidine) precursor, which was prepared from nitrile oxide components as an aminoacyl or peptidyl equivalent. This nitrile oxide-mediated C-N bond formation was also used for peptide macrocyclization, in which the amidoxime group was converted to peptide bonds under mild acidic conditions. Syntheses of the cyclic RGD peptide and a peptidomimetic using both approaches and the inhibitory activity against integrin-mediated cell attachment are presented.
Introduction
The backbone modification of amide bonds 1 in bioactive peptides is one of the most promising approaches for improving the resistance toward degradation by peptidases. 1 A number of peptide bond isosteres that reproduce the electrostatic properties and secondary structure conformations have been reported. 2 Reduced amide bonds (-CH 2 -NH-) 2 with a positively charged secondary amine provide a flexible and hydrogen bond-donating substructure ( Figure 1 ). The success of this substructure was exemplified by several enzyme inhibitors of HIV-1 protease 3 and neuronal nitric oxide synthase. 4 Alkene dipeptide isosteres (-CR=CH-, R = H, F or Me) 3 2,5 also represent steady-state peptide bond mimetics. This motif has been employed for the preparation of functional probes to identify indispensable peptide bonds. During the course of our medicinal chemistry studies using these isosteres, it was demonstrated that a heavy atom corresponding to the carbonyl oxygen in peptide bonds favorably modulates the local and global peptide conformations.
6
The uncharged form of amidines 4 resembles the peptide bond structures 1, in which both imino-and amino-functional groups share an sp 2 -carbon. Under physiological conditions, amidines are protonated and the positive charge of the conjugated acid is delocalized over two nitrogens. The characteristic substructure 4' can be viewed as a modified motif of the peptide bond and/or reduced amide structure. However, there are few reports on amidine-type peptide bond isosteres 4, 7, 8 while acyclic amidines 9 and cyclic amidines 10 have been utilized as an equivalent of the basic guanidino group for several bioactive molecules.
Whereas amidines have been synthesized directly by the Pinner reaction 7,8b or coupling of imidyl chlorides with amines, these reactions are not applicable to peptidyl amidine synthesis because of the harsh reaction conditions or arduous substrate preparation. We postulated that amidoximes (N-hydroxyamidines) 8 represents an appropriate key precursor for peptidyl amidine synthesis, which is obtained by coupling of nitrile oxides 6 with nucleophilic amines 7 (Scheme 1).
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Reduction 10 or hydrolysis under mild acidic condition 12 of the key amidoximes 8 would provide the target peptidyl amidines 4 or the parent peptide bonds 1, respectively. It was also expected that the highly reactive nitrile oxides 6 derived from peptide aldoximes 5 could be exploited as active ester equivalents for fragment condensation to prepare various protected peptides and peptidomimetics.
Herein we describe a novel approach to the synthesis of peptides and amidine-type peptidomimetics via peptide amidoximes.
Results and Discussion

Preparation of Amino Acid-derived Nitrile Oxide and the Application to the Synthesis of the Peptide Bond and Amidine-type Peptidomimetics
Nitrile oxides are useful reactive species, which can be formed from aldoximes by treatment with a chlorinating agent and a weak base. 11 There have been a number of reports on 1,3-dipole cycloaddition of a nitrile oxide with olefin to produce isoxazoline derivatives, 13 whereas examples to utilize nitrile oxides as active ester equivalents are limited. We expected that α-aminoaldoximes and peptide aldoximes serve as useful precursors of reactive nitrile oxide components for peptide and peptidomimetic synthesis.
Initially, we optimized the coupling conditions of α-aminoaldoxime 9 14 and α-amino ester 12.
This consists of a two-step process including chlorination of aldoxime 9 and the subsequent nucleophilic attack of an amino ester 12 onto the nitrile oxide 11, which is derived from 10 under basic conditions (Table 1) . The major isomer of N-Boc-valine aldoxime 9a reacted with a NaOCl solution 11 followed by workup and treatment with the amino ester 12 to give the desired amidoxime (N-hydroxyamidine) product 13 in 77% yield (entry 1), while the minor isomer 9b produced a complex mixture of unidentified products by the same reagent (entry 2). This was presumably due to the concomitant formation of unstable nitrile oxide 11 under basic conditions of the first chlorination step. Treatment of both aldoxime isomers 9a,b with N-chlorosuccinimide (NCS) in DMF without base provided the same product 13 in satisfying yields (entries 3 and 4). Of note, the chlorination of 9a with NCS in CHCl 3 did not work, resulting in the recovery of the starting material. As such, a facile protocol to prepare amidoximes from the both isomers of amino acid-derived aldoximes was established.
Conversion processes from amidoxime 13 were next investigated. Hydrogenation of 13 with Raney Ni 10 cleaved the N-O bond to afford the expected amidine-type isosteric unit 14 in 67% yield (Scheme 2). Alternatively, hydrolysis of 13 under mild acidic conditions containing NaNO 2 gave the parent dipeptide unit 15 in 62% yield. 12 No epimerization of the amidoximes occurred during the coupling process, which was verified by comparing 15 with two authentic diastereomers prepared from the standard protocol for peptide synthesis.
Solid-phase Synthesis of Peptide Aldoxime and the Application of Nitrile Oxide-mediated
Coupling to Cyclic Peptide Synthesis
The nitrile oxide-mediated synthesis of peptides and peptidomimetics was applied to the solid-phase approach. We chose a cyclic RGD peptide 16, cyclo (-Arg-Gly-Asp-D-Phe-Val-) Cyclization of acyclic peptide aldoxime 21 by treatment with NCS followed by Et 3 N gave the amidoxime-containing peptide 22 in a moderate yield (36%, Scheme 4). The yield of aldoxime-mediated cyclization is comparable with approaches using the azide method or DPPA-mediated cyclizations (11-52% cyclization yields for the RGD peptide 16 and the derivatives). 15a Subsequently, amidoxime 22 was converted smoothly to amide 23a and amidine 23b in 46% and 95% yields by NaNO 2 -mediated acidic hydrolysis and Raney Ni-mediated hydrogenation, respectively. The protecting groups for Arg and Asp were cleaved off using a cocktail of 1 M TMSBr-thioanisole/TFA in the presence of m-cresol and 1,2-ethanedithiol (EDT) in a short time, providing the desired parent RGD peptide 16 and the peptidomimetic 17 in 87% and 73% yields, respectively. It is of note that no hydrolyzed product 16 was observed during the deprotection treatment of 23b and subsequent HPLC purification process.
Biological Activity of the Cyclic RGD Peptide with an Amidine-type Isosteric Unit for the
Gly-Asp Dipeptide.
The resulting cyclic RGD peptidomimetics 17 was evaluated for its inhibitory effect of integrin-mediated cell attachment ( Figure 2 ). Peptide 17 with an amidine moiety showed moderate inhibitory activity (IC 50 = 4.77 μM) compared with the original peptide 16 (peptide 16, IC 50 = 0.157 μM). The X-ray crystal structure of the α v β 3 integrin-cyclic RGD peptide complex indicated that the uncharged amide NH of Gly-Asp is located proximal to the integrin residue Arg216, which is likely to be involved in the interactions. 18 These results suggest that substitution of the Gly-Asp peptide bond with the positively charged amidine unit partially eliminated the highly potent binding affinity towards the α v β 3 integrin.
Conclusion
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tert-Butyl [(S)-1-(hydroxyiminomethyl)-2-methylpropyl]carbamate (9). To a solution of
